Synthesis and biological evaluation of new [Tc(N)(R2PS)]-based mixed compounds as analogues of WAY 100635


Synthesis and biological evaluation of new [Tc(N)(R2PS)]-based mixed compounds as analogues of WAY 100635

Bolzati, C.; Cavazza-Ceccato, M.; Refosco, F.; Salvarese, N.; Pietzsch, H.-J.; Bergmann, R.; Bandoli, G.

Aim: This study was focused on evaluating the applicability of a new labelling procedure to the preparation of Tc(N)‐based target specific compounds. The chemistry is based on the use of the [Tc(N)Cl(R2PS)(PPh3)] species (R2PS = alkyl‐phosphino‐thiolate ligand), which selectively reacts with an appropriate mono‐negative chelate, such as a dithiocarbamate (DTC), to give neutral [Tc(N)(R2PS)(DTC)] compounds. The 2‐methoxyphenylpiperazine (2‐MPP) pharmacophore, which displays a potent and specific affinity for 5HT1A receptors, was selected as functional group and conjugated to the dithiocarbamate unit through different spacers. Method: The synthesis of [99m/99gTc(N)(R2PS)(Ln)] complexes, and their in vitro stability as well as their biological in‐vitro and in‐vivo assays were investigated. Stability studies were performed by considering: i) stability toward transchelation with Cysteine and Glutatione ii) binding to the serum proteins; ii) stability in rat serum, human serum and rat liver homogenates. The in vitro affinity for the 5HT1A receptors of the technetium complexes was assessed by measuring the ability of the compounds to compete with [3H]‐8‐OH‐DPAT binding in isolated membranes from rat cerebral cortex. The biodistribution profile of the best radiolabeled compound and its in vivo stability were evaluated in Sprague‐Dawley rats. Results: [99mTc(N)(R2PS)(Ln)] complexes were prepared in high yield (>90%) using a multi‐step procedure. The chemical identity of 99mTc‐complexes was determined by HPLC comparison with the corresponding 99gTc‐complexes. All complexes were found to be inert toward transchelation with an excess of free Glutathione and Cysteine. No significant in vitro serum protein binding and no notable biotransformation of the native compound into different species by the in vitro action of the serum and liver enzymes were shown. Nanomolar affinities for the 5‐HT1A receptor were obtained for [99mTc(N)(PSiso)L3] (IC50 = 1.5 nM), a reduction of the affinity were observed for the other complexes as a function of the reduction of the alkyl chain length interposed between the DTC group and the bioactive molecule. A negligible brain uptake was displayed from in vivo distribution data of [99mTc(N)(PSiso)L3]. Conclusion This work describes the application of a new labelling procedure for incorporating a bioactive molecule into a stable dissymmetric 99mTc(N)‐complex. Despite the favourable binding properties, the lack of BBB penetration indicates that these particular complexes may not be useful for CNS‐receptor mapping. Further studies should be performed in order to clarify the reason for this behaviour and to evaluate the usefulness in peripheral applications.

  • Lecture (Conference)
    Annual Congress of the European Association of Nuclear Medicine (EANM) 2009, 10.-14.10.2009, Barcelona, Spain
  • Abstract in refereed journal
    European Journal of Nuclear Medicine and Molecular Imaging 36(2009)Suppl. 2, S220
    ISSN: 1619-7070

Permalink: https://www.hzdr.de/publications/Publ-13240
Publ.-Id: 13240